Main Industry
Food and Beverage
Main Product/Service
Providing comprehensive genetic testing solutions, from testing kits to one-stop analysis software, meeting various clinical and research needs
Next-Generation Genetic Testing
ACCUiN Next-Generation Gene Testing Kits are designed using Multiplex PCR and
Next-Generation Genetic Testing
ACCUiN Next-Generation Gene Testing Kits are designed using Multiplex PCR and
Founded Year
2014
Unified Business No.
54714095
Status
Active
Number of Employees
1100
Total Paid-in
Capital
222,450,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Exit Status
Emerging Stock Exchange(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ACCUiN Biotech was founded in 2021, focusing on Next Generation Sequencing (NGS) technology as its core, and is dedicated to developing high-quality NGS reagents and analysis software. Since its inception, the company has concentrated on the NGS field. Wi